Clinical trials
Phase 1/2 Carcinoma, Transitional Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbisko Therapeutics Co, Ltd | 1 |
| BeiGene | 1 |
| Evopoint Biosciences Inc. | 1 |
| Genmab | 1 |
| Klus Pharma Inc. | 1 |
| Lee's Pharmaceutical Limited | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| Pfizer | 1 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 9 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 2 |
| Endometrial Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Uterine Cervical Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.